|
OMIM |
Link |
Information gain |
01 |
|
EPO
|
[NCBI]
|
0.0222929
|
|
|
CDAN2
|
[NCBI]
|
0.00247646
|
|
|
CDAN3
|
[NCBI]
|
0.00221216
|
|
|
GHDD
|
[NCBI]
|
0.00158236
|
|
|
red cell phospholipid defect with hemolysis
|
[NCBI]
|
0.000553845
|
|
|
visceral neuropathy, familial, autosomal recessive
|
[NCBI]
|
0.000512118
|
|
|
kenny-caffey syndrome, type 2
|
[NCBI]
|
0.000479378
|
|
|
blue rubber bleb nevus
|
[NCBI]
|
0.000452463
|
|
|
megaduodenum and/or megacystis
|
[NCBI]
|
0.000409825
|
|
|
DHS
|
[NCBI]
|
0.00037672
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
0.000321809
|
|
|
RA
|
[NCBI]
|
0.000278903
|
|
|
anemia, microcytic
|
[NCBI]
|
0.000233959
|
|
|
HBB
|
[NCBI]
|
0.000222293
|
|
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
0.00018779
|
|
|
EGFR
|
[NCBI]
|
0.000155776
|
|
|
anemia, hypochromic microcytic
|
[NCBI]
|
0.000146313
|
|
|
KLK3
|
[NCBI]
|
0.00014622
|
|
|
CEACAM5
|
[NCBI]
|
0.000144364
|
|
|
NPHP1
|
[NCBI]
|
0.000144071
|
|
|
malaria, susceptibility to
|
[NCBI]
|
0.00013497
|
|
|
CF
|
[NCBI]
|
0.000124597
|
|
|
VEGF
|
[NCBI]
|
0.000124185
|
|
|
atransferrinemia
|
[NCBI]
|
0.000123713
|
|
|
DBA
|
[NCBI]
|
0.000120357
|
|
|
hyperferritinemia-cataract syndrome
|
[NCBI]
|
0.000119909
|
|
|
PRL
|
[NCBI]
|
0.000119499
|
|
|
SLC11A2
|
[NCBI]
|
0.000112621
|
|
|
chromosome 5q deletion syndrome
|
[NCBI]
|
0.000108084
|
|
|
pearson marrow-pancreas syndrome
|
[NCBI]
|
0.00010144
|
|
|
CHH
|
[NCBI]
|
0.000101386
|
|
|
myeloproliferative disease, autosomal recessive
|
[NCBI]
|
0.000100337
|
|
|
pancreatic insufficiency, combined exocrine
|
[NCBI]
|
0.000100337
|
|
|
atherosclerosis, premature, with deafness, nephropathy, diabetes mellitus, photomyoclonus, and degenerative neurologic disease
|
[NCBI]
|
0.000100337
|
|
|
anemia, dyserythropoietic congenital, type i
|
[NCBI]
|
9.95054e-05
|
|
|
temporal arteritis
|
[NCBI]
|
9.84616e-05
|
|
|
MPO
|
[NCBI]
|
9.52059e-05
|
|
|
HBA1
|
[NCBI]
|
9.32139e-05
|
|
|
EL1
|
[NCBI]
|
9.27801e-05
|
|
|
GFAP
|
[NCBI]
|
9.04209e-05
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
8.48254e-05
|
|
|
MAFK
|
[NCBI]
|
8.36224e-05
|
|
|
AFP
|
[NCBI]
|
7.69081e-05
|
|
|
NFE2
|
[NCBI]
|
7.51004e-05
|
|
|
DKC
|
[NCBI]
|
7.32956e-05
|
|
|
hydrops fetalis, idiopathic
|
[NCBI]
|
6.94487e-05
|
|
|
dehydrated hereditary stomatocytosis, pseudohyperkalemia, and perinatal edema
|
[NCBI]
|
6.39736e-05
|
|
|
dyserythropoietic anemia with thrombocytopenia
|
[NCBI]
|
6.39736e-05
|
|
|
majeed syndrome
|
[NCBI]
|
6.39736e-05
|
|
|
glutathione synthetase deficiency of erythrocytes, hemolytic anemia due to
|
[NCBI]
|
5.99108e-05
|
|
|
myelocerebellar disorder
|
[NCBI]
|
5.99108e-05
|
|
|
peroxidase and phospholipid deficiency in eosinophils
|
[NCBI]
|
5.99108e-05
|
|
|
beta thalassemia, dominant inclusion body type
|
[NCBI]
|
5.99108e-05
|
|
|
membranoproliferative glomerulonephritis, x-linked
|
[NCBI]
|
5.99108e-05
|
|
|
mevalonic aciduria
|
[NCBI]
|
5.66799e-05
|
|
|
CRH
|
[NCBI]
|
5.22968e-05
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
5.15114e-05
|
|
|
SLC25A37
|
[NCBI]
|
5.12677e-05
|
|
|
TTC7A
|
[NCBI]
|
5.12677e-05
|
|
|
SEC15L1
|
[NCBI]
|
5.12677e-05
|
|
|
EPB49
|
[NCBI]
|
5.12677e-05
|
|
|
FUT1
|
[NCBI]
|
5.12677e-05
|
|
|
elliptocytosis, rhesus-unlinked type
|
[NCBI]
|
4.97097e-05
|
|
|
HFE4
|
[NCBI]
|
4.7938e-05
|
|
|
glutathione synthetase deficiency
|
[NCBI]
|
4.7938e-05
|
|
|
hyperlysinemia
|
[NCBI]
|
4.63474e-05
|
|
|
CD
|
[NCBI]
|
4.6333e-05
|
|
|
KLF1
|
[NCBI]
|
4.6159e-05
|
|
|
ACHE
|
[NCBI]
|
4.42482e-05
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
4.36398e-05
|
|
|
orotic aciduria i
|
[NCBI]
|
4.2196e-05
|
|
|
wilson disease
|
[NCBI]
|
4.20195e-05
|
|
|
kaposi sarcoma
|
[NCBI]
|
4.12449e-05
|
|
|
HAMP
|
[NCBI]
|
4.10465e-05
|
|
|
CHNG1
|
[NCBI]
|
4.01966e-05
|
|
|
NOS2A
|
[NCBI]
|
3.99662e-05
|
|
|
pycnodysostosis
|
[NCBI]
|
3.8295e-05
|
|
|
hyperlipoproteinemia, type i
|
[NCBI]
|
3.8295e-05
|
|
|
CYBRD1
|
[NCBI]
|
3.75443e-05
|
|
|
ADD3
|
[NCBI]
|
3.75443e-05
|
|
|
MAFG
|
[NCBI]
|
3.75443e-05
|
|
|
NFE2L1
|
[NCBI]
|
3.75443e-05
|
|
|
LAMA4
|
[NCBI]
|
3.75443e-05
|
|
|
ICMT
|
[NCBI]
|
3.75443e-05
|
|
|
TRMA
|
[NCBI]
|
3.74271e-05
|
|
|
GATA1
|
[NCBI]
|
3.62024e-05
|
|
|
OPTB3
|
[NCBI]
|
3.58291e-05
|
|
|
robinow syndrome, autosomal recessive
|
[NCBI]
|
3.509e-05
|
|
|
TF
|
[NCBI]
|
3.37681e-05
|
|
|
JBS
|
[NCBI]
|
3.37143e-05
|
|
|
hemangioma-thrombocytopenia syndrome
|
[NCBI]
|
3.30719e-05
|
|
|
CSF2
|
[NCBI]
|
3.2415e-05
|
|
|
TFRC
|
[NCBI]
|
3.2415e-05
|
|
|
ADD2
|
[NCBI]
|
3.24002e-05
|
|
|
SLC25A19
|
[NCBI]
|
3.24002e-05
|
|
|
TNF
|
[NCBI]
|
3.1502e-05
|
|
|
IL3
|
[NCBI]
|
3.11082e-05
|
|
|
F3
|
[NCBI]
|
3.09787e-05
|
|
|
pulmonary fibrosis, idiopathic
|
[NCBI]
|
3.07528e-05
|
|
|
GATA2
|
[NCBI]
|
2.90798e-05
|
|
|
megaloblastic anemia 1
|
[NCBI]
|
2.87564e-05
|
|
|
EPOR
|
[NCBI]
|
2.83498e-05
|
|
|
AQP1
|
[NCBI]
|
2.82312e-05
|
|
|
HBD
|
[NCBI]
|
2.72092e-05
|
|
|
PRDM16
|
[NCBI]
|
2.66254e-05
|
|
|
MAP4
|
[NCBI]
|
2.66254e-05
|
|
|
TNFSF6
|
[NCBI]
|
2.59058e-05
|
|
|
KLF2
|
[NCBI]
|
2.46811e-05
|
|
|
PGP
|
[NCBI]
|
2.46811e-05
|
|
|
wolman disease
|
[NCBI]
|
2.4077e-05
|
|
|
USF2
|
[NCBI]
|
2.3074e-05
|
|
|
LPIN2
|
[NCBI]
|
2.17064e-05
|
|
|
GSS
|
[NCBI]
|
2.17064e-05
|
|
|
JMJD6
|
[NCBI]
|
2.17064e-05
|
|
|
ADA
|
[NCBI]
|
2.13844e-05
|
|
|
ERAF
|
[NCBI]
|
2.05179e-05
|
|
|
VDR
|
[NCBI]
|
2.02535e-05
|
|
|
CSF1R
|
[NCBI]
|
1.94684e-05
|
|
|
IL23A
|
[NCBI]
|
1.94684e-05
|
|
|
ADD1
|
[NCBI]
|
1.94684e-05
|
|
|
G6PD
|
[NCBI]
|
1.8954e-05
|
|
|
KITLG
|
[NCBI]
|
1.81557e-05
|
|
|
HEPH
|
[NCBI]
|
1.76825e-05
|
|
|
IKZF1
|
[NCBI]
|
1.76825e-05
|
|
|
IBD1
|
[NCBI]
|
1.63398e-05
|
|
|
CSF1
|
[NCBI]
|
1.62024e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
1.59878e-05
|
|
|
INHBA
|
[NCBI]
|
1.55491e-05
|
|
|
PLA2G2A
|
[NCBI]
|
1.55491e-05
|
|
|
CGD
|
[NCBI]
|
1.5315e-05
|
|
|
GIST
|
[NCBI]
|
1.46908e-05
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
1.42273e-05
|
|
|
SDS
|
[NCBI]
|
1.40804e-05
|
|
|
SLE
|
[NCBI]
|
1.40354e-05
|
|
|
HHT
|
[NCBI]
|
1.39355e-05
|
|
|
MAPK14
|
[NCBI]
|
1.38512e-05
|
|
|
HBA2
|
[NCBI]
|
1.36638e-05
|
|
|
DKC1
|
[NCBI]
|
1.289e-05
|
|
|
giant platelet syndrome
|
[NCBI]
|
1.20927e-05
|
|
|
ALPS
|
[NCBI]
|
1.20927e-05
|
|
|
SPTB
|
[NCBI]
|
1.20339e-05
|
|
|
AK1
|
[NCBI]
|
1.20339e-05
|
|
|
FTL
|
[NCBI]
|
1.16393e-05
|
|
|
SMPD1
|
[NCBI]
|
1.0567e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
9.56191e-06
|
|
|
NP
|
[NCBI]
|
8.07816e-06
|
|
|
TNFRSF6
|
[NCBI]
|
8.07816e-06
|
|
|
NDP
|
[NCBI]
|
7.85147e-06
|
|
|
TFR2
|
[NCBI]
|
7.85147e-06
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
7.63894e-06
|
|
|
LPL
|
[NCBI]
|
7.21345e-06
|
|
|
SLC11A1
|
[NCBI]
|
7.01956e-06
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
6.46395e-06
|
|
|
CAT
|
[NCBI]
|
6.07787e-06
|
|
|
XDH
|
[NCBI]
|
4.99414e-06
|
|
|
CHS
|
[NCBI]
|
4.84174e-06
|
|
|
LIPC
|
[NCBI]
|
4.80689e-06
|
|
|
TFPI
|
[NCBI]
|
4.73059e-06
|
|
|
PTH
|
[NCBI]
|
4.34575e-06
|
|
|
STAT5A
|
[NCBI]
|
4.20562e-06
|
|
|
SLC4A1
|
[NCBI]
|
4.20562e-06
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
3.98621e-06
|
|
|
ALB
|
[NCBI]
|
3.87157e-06
|
|
|
STAT1
|
[NCBI]
|
3.77766e-06
|
|
|
PXE
|
[NCBI]
|
3.61656e-06
|
|
|
IL10
|
[NCBI]
|
3.57931e-06
|
|
|
PD
|
[NCBI]
|
3.07262e-06
|
|
|
factor v deficiency
|
[NCBI]
|
2.57178e-06
|
|
|
NF1
|
[NCBI]
|
2.47908e-06
|
|
|
CRC
|
[NCBI]
|
2.29275e-06
|
|
|
HFE
|
[NCBI]
|
2.27386e-06
|
|
|
JAK2
|
[NCBI]
|
1.45702e-06
|
|
|
LCAT
|
[NCBI]
|
1.40252e-06
|
|
|
CVID
|
[NCBI]
|
8.88349e-07
|
|
|
FMF
|
[NCBI]
|
5.90503e-07
|
|
|
IL6
|
[NCBI]
|
4.856e-07
|
|
|
LEP
|
[NCBI]
|
3.81227e-07
|
|
|
CP
|
[NCBI]
|
3.67649e-07
|
|
|
TNFSF10
|
[NCBI]
|
3.4171e-07
|
|
|
GHRH
|
[NCBI]
|
3.4171e-07
|
|
|
IL2
|
[NCBI]
|
2.73089e-07
|
|
|
HP
|
[NCBI]
|
9.79451e-08
|
|
|
ADM
|
[NCBI]
|
3.7527e-08
|
|